The data presented in this paper corroborate the hypothesis that one of the atropine effects on slowing down myopia depends on its ability to stimulate ECM (collagen and fibronectin) biosynthesis in scleral fibroblast cells, thus thickening the scleral tissue and reducing its elasticity and tendency to prolapse. The gene discussed is FN1; the disease is myopia.